Predicting Early Nerve Damage in Adults With Type 1 Diabetes
Studies nerve tests to predict early nerve damage in type 1 diabetes.
Plain-language title generated from the registry record
Registry title: Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
Key facts
- Where
- Aalborg, DenmarkSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Source: NCT05546138, who can take part
Where in Denmark
- Aalborg University HospitalAalborg, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Aalborg University Hospital
- Trial code
- NCT05546138
- Record updated
- 28 June 2024
- Original description
Predicting early onset neuropathy in people with type 1 diabetesRead full original descriptionShow less
Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy (NeuroPredict)
Predicting early onset neuropathy in people with type 1 diabetes
Inclusion: Men and women aged 18-80 years; Diagnosed with diabetes (of any type); No clinically established diabetic peripheral neuropathy at inclusion.
Exclusion: Alcohol or drug abuse within the last year (prior to inclusion); Chemotherapy (prior or within study period) or experimental medicine; Previous amputations; Known hematologic disorders resulting in a markedly reduced ability to stop small bleedings; Severe skin diseases or diseases known to cause neural damage; Severe vitamin deficiencies; Inability to understand or comply with the examinations; Planned or likely discontinuation of care at Aalborg University Hospital; Severe limb ischemia; Active diabetic foot ulcers; Pregnancy at inclusion.